- Home
- SIBN
SIBN
SI-BONE Inc.
as 11-07-2025 3:53pm EST
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
Upcoming Earnings Alert:
Get ready for potential market movements as SI-BONE Inc. SIBN prepares to release earnings report on 10 Nov 2025.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | SANTA CLARA |
| Market Cap: | 606.1M | IPO Year: | 2018 |
| Target Price: | $24.60 | AVG Volume (30 days): | 364.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.56 | EPS Growth: | N/A |
| 52 Week Low/High: | $11.70 - $20.05 | Next Earning Date: | 11-10-2025 |
| Revenue: | $185,262,000 | Revenue Growth: | 22.93% |
| Revenue Growth (this year): | 19.94% | Revenue Growth (next year): | 16.48% |
Stock Insider Trading Activity of SI-BONE Inc. (SIBN)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| DUNN JEFFREY W | SIBN | Director | Nov 3 '25 | Sell | $14.80 | 293 | $4,337.51 | 10,831 | |
| RECUPERO ANTHONY J | SIBN | President, Commercial Ops | Oct 2 '25 | Sell | $14.25 | 3,311 | $47,197.21 | 273,731 | |
| Maheshwari Anshul | SIBN | Chief Financial Officer | Oct 2 '25 | Sell | $14.20 | 3,311 | $47,012.77 | 212,691 | |
| Pisetsky Michael A | SIBN | SVP, Ops & Adm/Chief Legal Ofr | Oct 2 '25 | Sell | $14.20 | 3,128 | $44,582.86 | 256,556 | |
| RECUPERO ANTHONY J | SIBN | President, Commercial Ops | Aug 18 '25 | Sell | $15.62 | 3,833 | $59,875.08 | 273,731 | |
| Maheshwari Anshul | SIBN | Chief Financial Officer | Aug 18 '25 | Sell | $15.57 | 3,461 | $53,880.96 | 212,691 | |
| FRANCIS LAURA | SIBN | Chief Executive Officer | Aug 18 '25 | Sell | $15.60 | 11,343 | $176,939.80 | 419,704 | |
| Pisetsky Michael A | SIBN | SVP, Ops & Adm/Chief Legal Ofr | Aug 18 '25 | Sell | $15.63 | 3,329 | $52,054.67 | 256,556 |
Latest SI-BONE Inc. News
SIBN Breaking Stock News: Dive into SIBN Ticker-Specific Updates for Smart Investing
Zacks
4 days ago
PROCEPT BioRobotics Corporation (PRCT) Reports Q3 Loss, Beats Revenue Estimates
GlobeNewswire
5 months ago
SI-BONE to Present at Truist Securities MedTech Conference on June 17, 2025
GlobeNewswire
5 months ago
SI-BONE to Present at Goldman Sachs 46th Global Healthcare Conference on June 10, 2025
Zacks
5 months ago
Wall Street Analysts See a 34.22% Upside in Si-Bone (SIBN): Can the Stock Really Move This High?
Zacks
6 months ago
What Makes Si-Bone (SIBN) a Strong Momentum Stock: Buy Now?
Simply Wall St.
6 months ago
Earnings Update: SI-BONE, Inc. (NASDAQ:SIBN) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts
Zacks
6 months ago
Wall Street Analysts Think Si-Bone (SIBN) Could Surge 41.21%: Read This Before Placing a Bet
Simply Wall St.
6 months ago
SI-BONE First Quarter 2025 Earnings: Beats Expectations
Compare SIBN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SIBN SI-BONE Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.